XML 53 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOODWILL AND OTHER INTANGIBLE ASSETS
9 Months Ended
Sep. 30, 2013
GOODWILL AND OTHER INTANGIBLE ASSETS [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS
NOTE 7 — GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill:
The following table provides a summary of the activity in goodwill by segment for the nine months ended September 30, 2013 (in thousands):

   
Ophthalmic
  
Contract Services
  
Total
 
Balances at December 31, 2012
 $11,863  $20,296  $32,159 
Currency translation adjustments
     (2,594)  (2,594)
Balances at September 30, 2013
 $11,863  $17,702  $29,565 
              
Goodwill attributed to the ophthalmic segment was related to the Company’s acquisition of AVR in May 2011.  Goodwill attributed to the contract services segment relates to the Company’s acquisition of selected assets of Kilitch Drugs (India) Limited, principally its manufacturing facility in Paonta Sahib, India, in February 2012.

Other Intangible Assets:
      The following table sets forth information about the net book value of the Company’s intangible assets as of September 30, 2013 and December 31, 2012, and the weighted average remaining amortization period as of September 30, 2013 and December 31, 2012 (in thousands):

   
Gross
Amount
  
Accumulated Amortization
  
Net
Balance
  
Wgtd Avg Remaining Amortization Period
 
SEPTEMBER 30, 2013
            
Goodwill
 $29,565  $  $29,565   N/A 
Product licensing rights
  93,634   (33,572)  60,062  
13.2 years
 
Trademarks
  9,500   (765)  8,735  
27.6 years
 
Customer relationships
  6,133   (1,338)  4,795  
9.7 years
 
Non-compete agreement
  2,392   (951)  1,441  
2.4 years
 
    141,224   (36,626)  104,598     
                  
DECEMBER 31, 2012
                
Goodwill
 $32,159  $  $32,159   N/A 
Product licensing rights
  93,534   (29,880)  63,654  
13.8 years
 
Trademarks
  9,500   (528)  8,972  
28.3 years
 
Customer relationships
  6,460   (865)  5,595  
9.8 years
 
Non-compete agreement
  2,743   (579)  2,164  
3.2 years
 
   $144,396  $(31,852) $112,544     

During the nine month periods ended September 30, 2013 and 2012, the Company recorded amortization expense of $5.0 million and $5.1 million, respectively, related to its product licensing rights and other intangible assets.